Aeglea Biotherapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $498k | 21k | 23.28 |
2024-09-30 | $592k | 20k | 29.41 |
2024-06-30 | $207k | 8.8k | 23.51 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors